Gold nanoparticles: synthesis, characterization, and bioconjugation by Rahme, Kamil & Holmes, Justin D.
UCC Library and UCC researchers have made this item openly available.
Please let us know how this has helped you. Thanks!
Title Gold nanoparticles: synthesis, characterization, and bioconjugation
Author(s) Rahme, Kamil; Holmes, Justin D.
Editor(s) Lyshevski, Sergey E.
Publication date 2015-09
Original citation Rahme, K. and Holmes, J. D. (2015) 'Synthesis, Characterization, and
Bioconjugation,' in:   Lyshevski, S. E. (ed.), Dekker Encyclopedia of
Nanoscience and Nanotechnology, Third Edition, Seven Vol Set,
London, UK: CRC Press; Taylor & Francis, pp.1-11. isbn
9781439891346.




Access to the full text of the published version may require a
subscription.
Rights Copyright © 2014 From Dekker Encyclopedia of Nanoscience and
Nanotechnology, Third Edition by Sergey E. Lyshevski (editor).
Reproduced by permission of Taylor and Francis Group, LLC, a
division of Informa plc. This material is strictly for personal use
only. For any other use, the user must contact Taylor & Francis
directly at this address:
permissions.mailbox@taylorandfrancis.com. Printing,







Gold Nanoparticles: Synthesis Characterization and 
conjugation 
 
Kamil Rahme a,b,c and Justin D. Holmes b,c 
a Department of Sciences, Faculty of Natural and Applied Science, Notre Dame University 
(Louaize), Zouk Mosbeh, Lebanon 
b Materials Chemistry and Analysis Group, Department of Chemistry and the Tyndall 
National Institute, University College Cork, Cork, Ireland 
c Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN), Trinity 
College Dublin, Dublin 2, Ireland 
 

















Gold nanoparticles (Au NPs) with diameters ranging between 4-150 nm have been synthesized in 
water. The strong reducing agent sodium borohydride (NaBH4) was used to produce small Au NPs 
with diameter about 4 ± 1 nm. 15 and 30 nm Au NPs were obtained by a slightly modified Turkevich 
and Frens method using sodium citrate as both reducing and stabilizing agent at high temperature. The 
attempt to produce Au NPs with diameter larger than 30-40 nm by the Turkevich method resulted in 
an increase in the polydispersity and the shape diversity of the final Au NPs, indicating the 
importance of the trial of new reducing agents in the production of Au NPs especially for diameters 
above 40 nm.  Therefore, hydroxylamine-o-sulfonic acid (NH2SO4H) (HOS) was used here for the 
first time as a new reducing agent for HAuCl4 at room temperature to produce Au NPs with diameter 
of about 60, 90 and 150 nm. This new method using HOS is an extension of the approaches described 
to produce Au NPs with diameter above 40 nm by direct reduction. The obtained nanoparticles were 
characterized using uv-visible spectroscopy, dynamic light scattering (DLS) and transmission electron 
microscopy (TEM). Further biocojuguation on 15, 30 and 90 nm Au NPs were performed by grafting 
covalently Apolipoprotein E (ApoE) and Bovine Serum Albumin (BSA) through an ethylene glycol-
N-hydroxysuccinimide linker (NHS-PEG-S-S-PEG-NHS) making them very attractive for drug 
delivery and cell targeting. Finally, functionalized polyethylene glycol-based thiol polymers were also 
used to stabilize the pre-synthesized Au NPs-PEG-Protein. 
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Gold nanoparticles (Au NPs) have a strong absorption band and high luminescent properties, due to 
the surface plasmon resonance (SPR), originated from the coherent oscillations of conduction-band 
electrons on nanoparticle surface upon interaction with an electromagnetic radiation of appropriate 
wavelength.1  The SPR optical absorption and scattering properties of the Au NPs are also known to 
depend from the final size and shape of the nanoparticles, and to be very sensitive to the 
surrounding media and the aggregation state of the nanoparticles.2-6  Therefore, Au NPs have 
attracted researcher’s attention for their use as a very useful tool for a wide range of applications, 
including chemical sensing, optoelectronics, diagnostics, thermal therapy, drugs and gene 
delivery.2,3,5,7-16  Furthermore, the low cytotoxicity of Au NPs and their ease of bioconjuguation have 
contributed to the boom of gold nanoparticles in bionanotechnology ,17,18 many publications on the 
studies of the effect of nanoparticle size and shape on cytotoxicity, biodistribution, and interaction 
with biosystem have appeared recently.19-23  Therefore, the synthesis of Au NPs of different 
sizes/shapes has attracted much interest in the last few decades. Different ways to synthesize gold 
nanoparticles are now available in the literature, among which Au NPs are mainly produced through 
chemical reduction of gold precursor (typically HAuCl4). At first, Turkevish in 1951 reported on the 
formation of colloidal gold nanoparticles using trisodium citrate to reduce tetrachloroauric acid in 
water, later Frens published in 1971 an improved and slightly modified method still popular to days. 
Unfortunately, Au NPs obtained by the above methods are between 10 and 40 nm, with a larger size 
makes the Nps less monodisperse and irregular in shapes.24,25  
Methods to improve monodispersity and shape of gold nanoparticles when their diameter exceeds 50 
nm use a seeding growth strategy.26-28 Large Au NPs were formed by reducing gold HAuCl4 or A(III)-
surfactants (i.e CTAB or Triton X-100) complexes in the presence of Au NPs seeds with 
hydroxylamine hydrochloride or ascorbic respectively.29,30 When CTAB is present various shapes 
such as nanorods nanoprism etc. can be obtained by varying the synthesis conditions and mainly the 
CTAB concentration.30  However, Au NPs-CTAB are known to be toxic, and excess of CTAB in the 
media has to be removed prior to bological assys.31 Quasisphercal gold nanoparticles of diameter 
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ranging from 15 to 300 nm were synthesized by different authors including us, through seeded growth 
methods using 2-mercaptosuccinic acid, hydroquinone, hydroxylamine hydrochloride and H2O2.28,32-34 
Moreover, seeding growth methods may not always give a homogeneous growth of all the seeds and 
some smaller nanoparticles can sometimes be found in solution (usually less than 5 %). 
Nanotechnology and nanomedecine require improved synthetic methods for nearly monodisperse and 
stable colloidal solutions, avoiding the use of cytotoxic chemicals. Amine containing molecules are 
well known to be widely used as reducing agents for nanoaprticles synthesis and stabilization.35  
When polyelectrolytes such as chitosan, polyallylamine and polyethylenimine are present during the 
synthesis of nanoparticles, positively charged nanoparticles can be otained,36 the presence of this 
positive charges on the surface of the nanoparticles maybe of benifits for electrostatic complexation 
for biomolecules such as the phosphate esters backbones of the nucleic acid,37-39 while the more 
general process for the bioconjugation of nanoprticles is known to occur through formation of a 
biologically stable amide linkage between the NH2 groups of the biomolecules and carboxylic acid at 
the surface of the nanoparticles or vice versa.40-42  The attachment of biomolecules such as peptides, 
proteins and other targeted ligands containing specific molecules that recognize receptors on various 
cell lines on the surface of nanoparticles plays a key role not only for their interactions with biological 
tissues, but also in their biological functions and cellular uptake, that can facilitate their use in drug 
delivery, diagnosis and therapeutics.43-48 
Here we report a fast and simple protocol for the synthesis of seedless gold nanoparticles colloidal 
solutions with size range between 4 and 150 nm in water.49,50  We also show in this study the failure 
of the attempt to obtain Au NPs with diameter larger than 30-40 nm via the citrate reduction, due to 
an increase in the polydispersity and the shape diversity of the final Au NPs.26 This result indicates the 
importance of the trial of new reducing agents in the production of Au NPs especially for diameters 
above 40 nm. Therefore, we show in this study for the first time that we can obtain Au NPs with 
diameters of about ~60, ~80 and ~150 nm Au NPs by using HOS as a new reducing agent for 
HAuCl4, 3H2O at room temperature. Our results from dynamic light scattering based on the Rayleigh 
scattering, known for spherical nanoparticles, show that the obtained nanoparticles were not 
polydisperse (PdI < 0.15), as further justified by electron microscopy and UV-visible spectroscopy. 
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This simple method can serve as a complement for the commonly used Turkevich and Frens method 
in the direct production of Au NPs.  Further biocojuguation on 15, 30 and ~ 90 nm PEGylated Au NPs 
was performed by grafting Apolipoprotein E (ApoE) and Bovine Serum Albumin, via an amide 
linkage using an amine reactive functional group N-hydroxysuccinimide, that easily react with amino 
groups from the protein in aqueous media with a pH between 8 and 10, making the Au NPs-PEG-
Protein more attractive for biomedical applications.42  More works are now in progress in order to 
understand the effect of temperature and pH on the synthesis of Au NPs via hydroxyl-O-sulfonic acid 
reduction, and to graft other biomolecules such as transferrin etc, as well as on testing these AuNPs-
biomolecules conjugates in biology. 
II. Materials and methods 
A.  Chemicals and Materials: 
Tetrachloroauric acid trihydrate (HAuCl4.3H2O), gold (III) chloride (AuCl3), sodium citrate 
(C6H5Na3O7.2H2O), sodium borohydride (NaBH4), hydroxylamine-o-sulfonic acid (NH2SO4H), 
sodium hydroxide (NaOH), 4,7,10,13,16,19,22,25,32,-35,38,41,44,47,50,53Hexadecaoxa-28,29-
dithiahexapenta-contanedioic acid di-N-succi-nimidyl ester (NHS-PEG-S-S-PEG-NHS) with n=7 
Bovine Serum Albumin (BSA) were purchased from Sigma Aldrich. Thiol terminated poly(ethylene 
glycol) methyl ether, Mw = 2100; 5400; and 10800 g mol-1 were purchased from Polymer Source. 
Apolipoprotein E (ApoE) Human Plasma, Very Low Density Lipoprotein was purchased from 
rpeptide Startech Scientific; the 50 mM NH4HCO3 medium was exchanged with citric buffer (pH ~7) 
by dialysis at 4°C during 24 hours prior to use.  
 
B.  Preparation, Bioconjugation of Au NPs.  
Diameter of 4 ± 1nm Au NPs: To an aqueous solution (150 mL) of HAuCl4.3H2O (0.25 mmol L-1) 
was added 0.22 mL of a 340 mmol L-1 sodium citrate aqueous solution and the mixture was stirred 
vigorously in an ice bath. To this solution was added 0.375 mL of an ice cold solution of NaBH4 (100 
mmol L-1). An instantaneous colour change from pale yellow to deep red-orange was noted after 
addition of NaBH4.  The AuNPs obtained with this procedure were approximately 4 ± 1nm. 
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Diameter of ~15 nm: 50 mL of an aqueous solution of HAuCl4.3H2O (0.25 mmol L-1) was heated to 
95°C while stirring. 0.17 mL of a 340 mmol L-1 sodium citrate aqueous solution was rapidly added. 
The colour of the solution changed from pale yellow to dark blue, and then to deep red-burgundy 
within about 8 minutes.  Stirring and heating was maintained during 1h after addition of sodium 
citrate. The heat was then removed and the solution was kept under stirring, until cooled to room 
temperature. The Au NPs obtained with this procedure were ~ 15 ± 2.5 nm.28 
Diameter of ~30 nm:  A similar method used for the 15 nm Au NPs is used with a slight change were 
the pH of the solution was adjusted to pH ~ 7 with NaOH before heating and the heat was maintained 
for 4 hours after addition of sodium citrate. The AuNPs obtained with this procedure were 
approximately 30 ± 4 nm.50 
Diameters of ~60 nm, ~90 nm and ~150 nm AuNPs: For Au NPs, larger than 30 nm, a very weak 
reducing agent hydroxylamine-o-sulfonic acid was used in this study for the first time to reduce 
HAuCl4.3H2O in the presence of sodium citrate at room. For ~60 nm AuNPs, to 150 mL of an 
aqueous solution of 0.1 mmol L-1HAuCl4.3 H2O and 0.48 mmol L-1 sodium citrate was added 
Hydroxylamine-o-sulfonic acid (final concentration 0.15 mmol L-1). After addition of HOS the colour 
of the solution changed from pale yellow to colourless in about 5 minutes, then to gray, blue, and then 
slight red-pink after several hours, the solution was kept under stirring for about 18 hours. The Au 
NPs obtained were 61 ± 6.5 nm. By increasing the concentration of HAuCl4 from 0.1 to 0.2 and 0.5 
mmol L-1 respectively, while keeping all the other conditions fixed, we found that the size of Au NPs 
increased from 61 ± 6.5 nm to ~91 ± 9 nm and ~148 ± 22 nm respectively.  
PEGylation of Gold Nanoparticles: PEGylation was performed by adding PEG280-S-S-PEG280-NHS 
to the Au NP solution, stirring was maintained for 2 hours.  
Protein bioconjugation: The pH of the Au NPs-PEG-NHS solution was adjusted to pH between 
7.5~9 by adding few drops of NaOH (0.1 M) solution, followed by the addition of the protein solution 
(~ 50 protein/particle) in citric buffer addition to the Au NP colloidal solution. The solution was left 
to react under shaking for 4 hours prior to DLS measurement. 
7 
 
PEGylation of Au NPs- Protein conjugate: A solution of mPEG-SH of the desired molecular 
weight was added to a solution of citrate-capped Au nanoparticles with stirring.  The solution was 
stirred for ~1 h allowing mPEG-SH to be grafted on the Au NPs surface prior to DLS measurement. 
 
III. Instrumentation 
Optical spectra were obtained on a CARY Uv−vis spectrophotometer with a Xenon lamp (300−900-
nm range, 0.5 nm resolution). 
Dynamic Light Scattering (DLS) and Zeta Potential: Measurements were carried out with the 
Malvern instrument (Zeta sizer Nano series) at 25°C. Measurements on each sample were performed 
in triplicate. 
Transmission Electron Microscopy (TEM): A drop of nanoparticles dispersion was first placed on a 
carbon-coated TEM copper grid (Quantifoil, Germany) and left to air-dry, before being introduced 
into the sample chamber of the TEM.  Samples were analysed using a JEOL JEM-2100 TEM 
operating at 200 kV.  All images were recorded on a Gatan 1.35 K × 1.04 K × 12 bit ES500W CCD 
camera.  TEM images were analysed using Image J software. 
 
IV. Results and Discussion 
A. Chemical Synthesis and characterization of Au Nanoparticles . 
Gold nanoparticles with size dependent optical properties are now very useful in different 
field of nanotechnology.46,51,52  Different ways to produce gold nanoparticles can be found in 
the literature.29,36,53-57  The most used techniques are based on the reduction of gold chloride 
precursor mainly of HAuCL4 by different reducing agent.24,25,28,29,36,53-58  However, no 
universal reducing agent in known yet in order to produce monodisperse gold nanoparticles 
of different sizes, instead different ways such as seeding growth methods and different 
reducing agents with variable strength are usually used.26-28,32,49  Chemical reduction of 
HAuCL4 with a strong reducing agent such as sodium borohydride or hydrazine occurs very 
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fast and in non controllable manner to produce gold nanoparticles usually with diameter 
below 5 nm.49  While the reduction with sodium citrate produce Au NPs with diameters 
larger than 8-9 nm and is more widely used until to date for the synthesis of Au nanoparticles 
and further studied.50,59,60  The mechanism of the formation of Au nanoparticles obtained by 
citrate reduction of HAuCl4 was found to contain four steps as concluded Polte et al. from 
their study using in-situ nanoparticle growth monitoring via XANES and SAXS.59  Moreover, 
Ji et al. have described two pH dependents mechanisms for the formation of Au nanoparticles 
with citrate, whereby Au nanoparticles were found to form by fast, random particle 
attachment and ripening for solutions with pH < 6.5, whilst slower nucleation and ripening 
was observed for synthesis solutions with pH 6.5-7.7.50  In our study presented here, we have 
synthesized Au NPs with diameters ranging between 4-and 150 nm using three different 
reducing agents. The produced Au NPs have size dependent optical absorption as shown from 
the characterization by Uv−visible absorption spectroscopy (Figure 1), transmission electron 
microscopy TEM (Figure 2 and 3) and dynamic light scattering (Figure 4). The figure 1 show 
the Uv-visible spectra of the nearly monodisperse different diameters Au nanoparticles (~4, 
~15, ~30, ~60, ~90 and ~150 nm) synthesized in this study, a clear red shift of the plasmon 
absorption maximum (λmax) from 513 nm to 600 nm accompanied with a further broadening 
of the absorbance band from 50 nm to 380 nm with increasing Au nanoparticle diameter from 
~4 ± 1 nm to ~ 148 ± 22 nm respectively is observed. The red shift and the SPR broadening is 
due to a higher oscillation modes (quadrupole, octopole absorption and scattering) that also 
affect the extinction cross section with increasing size.61 The use of the strong reducing agent 
sodium borohydride in the presence of sodium citrate as stabilizing agent at room 
temperature allowed us to produce Au NPs with diameter of 4 ± 1 nm as resulted from TEM 
analysis (Figure 2 (a)), while the 15 nm Au nanoparticles were obtained by chemical 
reduction of HAuCl4 with sodium citrate at pH < 6.5 and at a temperature of about 95 °C, 
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suggesting that Au NPs form by fast, random particle attachment and ripening as outlined by 
Ji et al. (Figure 2(b)).50  Histograms of the nanoparticle diameters presented on the right of 
each TEM image are obtained from TEM image analysis using Image J software. An attempt 
to produce larger Au nanoparticles at pH < 6.5 was also performed through the decrease of 
both the citrate/HAuCl4 ratio and the temperature. Our results here show clearly that when the 
nanoparticles increase above 35 nm for a ratio citrate/HAuCl4 of 0.76 different shapes with 
mostly elongated particles were obtained in the final solution as shown in the figure 3(a). 
However, 30 nm Au nanoparticles with better circularity and polydispersity used in this study 
were obtained by a previously reported method by Ji et al. through the chemical reduction of 
HAuCl4 with sodium citrate at pH > 6.5 (pH ~7 adjusted by addition of Na OH 1M to the 
solution mixture) and at a temperature of about 95 °C, the increase in the pH to about 7 
results in a more controlled synthesis based on slower nucleation and ripening, the resulted 
nearly spherical Au nanoparticles with diameter 32 ± 4.5 nm are shown in figure 2 (c).50  
Further decreasing in the ratio of citrate/HAuCl4 to 0.35 and 0.26 as well as the temperature 
from 100 to about 70 °C lead only to a slight increase in the size of the nanoparticles with a 
large increase polydispersity and shape diversity as shown in the TEM images presented in 
the figure 3 ((c), and (d)). In fact we show here that it is not possible to obtain large Au NPs 
by simply using the Turkevich and Frens method via a simultaneous decrease of the citrate/ 
HAuCl4 and the temperature.  
Large Gold nanoparticles are usually obtained through a seeding growth method.26,32,34  We 
have reported recently on the synthesis of Au NPs with diameters ranging between 15 and 
170 nm in aqueous solution using a seed-mediated growth method, employing hydroxylamine 
hydrochloride as a reducing agent.28  Here we report on a new method for the synthesis of Au 
NPs of diameters above 50 nm using a simple and one step synthesis based on the use of  
hydroxylamine-o-sulfonic acid (HOS) as a new reducing agent of HAuCl4 at room 
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temperature and in the presence of sodium citrate as reducing agent. In fact, Zou et al. 
reported a seed-mediated synthesis of branched gold nanoparticles with the assistance of 
citrate using hydroxylamine sulfate in presence of Au NPs-citrate seeds.62  Rozenskranz 
found in 1973 that exposure of DNA solutions to low levels (2 mmol L-1) of hydroxylamine-
O-sulfonic acid (HOS) resulted in limited degradation without significant change to the 
thermal helix-coil profile of the DNA,63 these results makes HOS use as a biologically 
friendly reducing agent and a candidate of choice. Nearly monodisperse Au NPs with 
diameter of about ~60, ~90 and ~150 nm with size dependent optical properties (figure 1) 
were obtained in this study as shown in the figure 2 (d), (e) and (f), from the electron 
micrographs of the Au nanoparticles obtained via the reduction of 0.1, 0.2 and 0.5 mmol L-1 
HAuCl4. 3H2O with HOS at 0.155, 0.31 and 0.775 mmol L-1 respectively.  Our results from 
TEM image analysis using Image J software show that the size was found to increase from 61 
± 6.5 nm to 92 ± 12 nm and 148 ±  22 nm when the concentration of both HAuCl4 and HOS 
increases, while keeping the ratio HOS/ HAuCl4 constant at 1.55. The circularity of the 
resultant nanoparticles was also not very affected and nearly spherical shapes were obtained. 
In fact HOS seems to be a very weak reducing agent, therefore allowing a slow reduction of 
HAuCl4 (more than 18 hours) that lead to a nearly monodisperse colloidal solution. Figure 4 
shows the diameter distribution by intensity of the as synthesized Au nanoparticles with mean 
diameters of ~15, ~30, ~60, ~90, and ~150 nm before conjugation.  The size distribution peak by 
intensity was found to shift from ~20 nm (Zav 17 nm) to ~ 170 nm (Zav = 161 nm) when the size 
increases from ~15 ± 2.5 nm to 148 ± 22 nm (results from TEM). The zeta potential of all the Au 
nanoparticles was in the range between -31 for 15 nm Au NPs to -40 mV for ~ 30 nm. As discussed 
previously, we note here that the final size of the obtained nanoparticles from HOS was found to 
depend on both the reducing agent and HAuCl4 concentrations. This new method presented in 
this study using NH2SO4H (HOS) can be applied as an extension of the approaches described 
to produce Au NPs with diameter above 40 nm by direct reduction. However, since both the 
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gold precursor and the reducing agents are acidic, the pH is expected to decreases when their 
concentration increases.14,50,64,65  More studies are now in progress to study the effect of pH 
and temperature on the final nanoparticles size distribution as well as the yield of this 
reduction. In fact, Au nanoparticles produced in this are electrostatically stabilized, and as 
such they are very sensitive to any change in the ionic strength and/or pH of the medium in 
which they are dispersed, which can induce nanoparticle aggregation.  We have demonstrated 
previously that conjugation on the surface of AuNPs-citrate either through Au-SH chemical 
bonding with polyethylene glycol PEG, or by auto-assembly of triblock and diblock 
surfactant polymers based on polyethylene oxide and polypropylene oxide can improve the 
stability and biocompatibility of the nanoparticles.6,28,60,66,67  Moreover, proteins such as BSA 
and other biomolecules are also known to increase the stability of nanoparticles under 
physiological condition.45,68-71 
B. Bioconjugation of Au NPs 
The presynthesized Au NPs in water mainly 15, 30 nm (obtained through the Turkevich/Frens 
method) and ~ 90 nm obtained by HOS reduction were used for further bioconjugation with different 
proteins attached through a biologically stable amide linkage in water. In this study ApoE protein, 
known to enhance the permeability of nanoparticles across the “Blood Brain Barrier” was attached 
on the 30 nm AuNPs (Scheme1),72,73 a similar method was also used to conjugate the 15 nm Au NPs 
BSA.42,74  As we previously reported, the stability of the Au NPs under physiological conditions 
(0.157 mol.L-1 NaCl) can be well improved by grafting a polyethylene glycol-based thiol polymers 
shell on their surface.28,67  We have also determined the number of PEG-SH ligands needed to coat the 
surface of a Au NP of a particular diameter and estimated the grafting density using thermal 
gravimetric analysis (TGA) and TEM.28  In this study, we have chosen to graft first a functional 
oligomer NHS-PEG280-S-S-PEG280-NHS, based on fourteen ethylene glycol units, thiol disulfide and 
N-hydroxy succinimide (NHS) reactive ester group as an active group on the Au NPs surface (Scheme 
1) used as both a stabilizing agent and chemical linker able to react with amino group of the protein in 
water.17,42,73,75,76  Therefore, the addition of NHS-PEG280-S-S-PEG280-NHS to the presynthesized Au 
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NPs colloidal solution resulted in the formation NHS functional polyethylene glycol layer grafted on 
the Au NPs surface, where NHS-PEG280-S is attached through a gold thiol (Au―S) chemical bond as 
shown in Scheme 1. The successful PEGylation of the Au NPs was confirmed by DLS/Zeta potential 
(ξ) measurements, where a slight increase in the size of nanopartciles of about 2-3 nm was detected 
(Figure 5), and ξ was found to decrease slightly from -40 to about -35 mV. After PEGylation, ApoE 
protein dispersed in a citric buffer solution (pH ~ 7) was added to the Au NPs-PEG-NHS solution 
(Scheme 1), the pH was adjusted to ~9, and the solution was left to react for about four hours under 
shaking. The protein was able to be grafted on the PEG layer of the Au NPs through formation of an 
amide linkage (NHCO) between the amino groups of the protein and the NHS at the surface of the Au 
NPs-PEG-NHS as confirmed by DLS (Figure 5). Figure 5 show a size increase of about 5 nm is after 
protein conjugation. Similarly, the Bovine serum Albumin was also grafted on the 15 nm AuNPs 
(Figure 6), the size was found to increase by about 4 nm after PEG-NHS attachment, and 7 nm after 
protein attachment. However, we note here that the conjugation of the 15 seems to cause a slight 
flocculation as can be detected from DLS measurements; indeed, no change in the initial red colour of 
the colloidal solution was observed. The filtration of the Au NPs-PEG-NHCO-BSA colloidal solution 
through a 0.2 μm nylon filter was found to remove the larger sizes flocks observed in DLS (Figure 6). 
Finally we note that number of protein used in this study was estimated to be 55 BSA proteins per 15 
nm AuNPs and about 158 ApoE per 30 nm AuNPs. 
Further stabilization of the AuNPs-Protein was also performed using a tiny amount of mPEG-SH 
2000, 5000, and 10 000 (Figure 7).  PEGylation of nanoparticles is well known to increase the 
stability of nanoparticles in biological fluids and to increase the circulation in the blood stream. 
However, the addition of the SH-PEG may also remove some the protein coating from the surface of 
the nanoparticles by ligand exchange.  Therefore the amount to SH-PEG added here was estimated in 
order to have a partial coverage of the AuNPs surface. Figure 7 show the results from DLS on the 
PEGylation of the 30 nm AuNPs-PEG-ApoE, an increase in the size of the AuNPs-PEG-ApoE by ~2, 
7 and 12 nm accompanied with an increase in the zeta potential from -34 mV, -28 and -20 mV (results 
not shown) with the increase of the PEG length from 47 to 122 and 245 EO units respectively. This 
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increase in the size and zeta potential indicate the successful attachment of the PEG on the Au NPs 
surface that might increase their stability.67  We note that from our results obtained in our previous 
study on PEGylation with a maximum coverage of the Au NPs surface with mPEG-SH, a larger 
increase in the nanoparticles size by about, ~8, ~15 and ~23 nm with the increase of the PEG length 
from 47 to 122 and 245 EO units respectively was observed, the zeta potential was also found to 
increase to ~ -8 ± 2 mV for the PEG with 245 EO units. These results can confirm that only a partial 
coverage with mPEG-SH is performed here, therefore leaving the proteins grafted on the Au NPs 
surface.  The effect of the PEGylation on biological applications (uptake/delivery protein stability and 
conformation etc…) will be evaluated in a future study.  
In this study, DLS was found to be a very sensitive technique for the characterization of dispersions of 
nanoparticles and nanoparticle –protein/polymer hybrids. In fact, DLS is also known as a method of 
choice for protein (and other biomolecule) molecular weight distributions in solution.77  
Consequently, the conjugation of protein and PEG can dramatically affect the Brownian motion of 
particles by introducing additional frictional drag and thus reducing nanoparticle diffusivity that 
allowed us to follow each step of conjugation (PEGylation/protein attachment).  As shown in Figures 
5, 6 and 7, a shift in the size distribution of Au NPs to bigger sizes after each step can confirm the 
successful grafting of PEG-NHS and proteins on the Au NPs-PEG surface without any noticeable 
aggregation of the colloidal solution, further confirmed by TEM (results not shown). A similar 
chemistry approach was also applied to attach ApoE protein on 15 and 90 nm Au NPs as well as can 
be used for other types of proteins (ie. Transferrin, etc...). The herein presented method is successful 
for bioconjuguation of gold nanoparticles in water, and can also be applied to other biologically active 
molecules (Folic acid etc...).  
 
Conclusions 
The successful applications of nanoparticles in biomedical science require a stable colloidal solution 
in complex media with a high ionic strength, a very low or no cytotoxic effect as well as coating with 
biomolecules of interest. In this study, a new method for synthesizing big size Au NPs between 60 
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and 150 nm through direct reduction of gold precursor using a hydroxylamine-o-sulfonic acid as weak 
reducing agent at room temperature was performed. The obtained nanoparticles were not polydisperse 
(PdI <0.17) and have size dependent optical properties.  In contrast, we show here that the citrate 
reduction method is not successful in producing Au NPs with sizes more than 40 -50 nm. Therefore, 
the above method represent an extension of the approaches described by Turkevich, Frens and others 
to produce Au NPs with a diameter above 50 nm without increasing polydispersity of the colloidal 
solution. Finally, bioconjugation of the obtained Au NPs with proteins make them very attractive for 
applications in biology, a concept to be investigated in future work. 
Table and Figure Captions 
 
 





Figure 2.  TEM micrographs of the Au NPs with diameter ~4 nm (a) obtained from NaBH4, 
~15 nm (b); ~30 nm (c) obtained from citrate, and ~60 nm (d); ~90 nm(e) and ~150 (f) nm 
obtained from HOS reduction. To the right of each picture a histogram showing the Au NPs 






Figure 3.  UV-visible spectra (a) of Au NPs obtained from the direct reduction with sodium 
citrate at different citrate/HAuCl4 at ~ 80 °C. The corresponding TEM micrographs ((b), (d), 
(e)) and colloidal solution of each ratio is also presented (c).  The histogram showing the 
nanoparticle diameters distribution obtained from TEM image analysis using Image J 
software for the ratio citrate/HAuCl4 0.76.  
 
Figure 4.  Size distribution by intensity obtained from DLS on the nearly monodisperse Au 
NPs obtained in this work, Au NPs with diameter ~60; ~90 and ~150 nm obtained by 
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reduction of HAuCl4 (0.1, 0.2 and 0.5 mmol L-1 respectively) with HOS at room temperature 
(PdI < 0.17). 
 
Scheme 1. formation Au NPs-PEG-NHS and grafting of ApoE protein on Au NPs-PEG-NHS 
in water, a similar synthesis was used to graft BSA on 15 nm Au NPs.  
 
Figure 5.  Size distribution by intensity obtained from DLS on 30 nm Au NPs-citrate before, 
and after PEGylation with NHS-PEG-S-S-PEG-NHS, and further attachment of ApoE protein 
through a biologically stable amide linkage; insert left (overall bioconjugation process 




Figure 6.  Size distribution by intensity obtained from DLS on 15 nm Au NPs-citrate before, 
and after PEGylation with NHS-PEG-S-S-PEG-NHS, and further attachment of BSA protein 
through a biologically stable amide linkage; insert left (overall bioconjugation process 
Scheme 1), conjugation on 15 nm Au NPs caused slight aggregation, the aggregated Au NPs 
were removed via filtration of the colloidal solution on 0.2 μm Nylon filter.  
 
Scheme 2. Further PEGylation of ~ 30 nm Au NPs-PEG-NHCO-APoE in water (mPEG-SH 




Figure 7.  Size distribution by intensity obtained from DLS on 30 nm Au NPs-PEG-NHCO-
ApoE (ApoE-AuNPs) before, and after PEGylation with mPEG-SH (Mw~2100, 5400 and 
10000 g mol-1) insert show the overall process Scheme 2). 
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